Clinical Trial

High-intensity Statin and Ezetimibe Therapy for Asymptomatic Patients With Positive Coronary Calcium

Study acronym: DECISION-CAL
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The aim of this study is to compare safety and efficacy between the aggressive treatment with combination of high-intensity statin and ezetimibe and the current standard lipid lowering treatment in asymptomatic patients with presence of coronary calcification.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-04-25.
Status change: Not Yet Recruiting → Recruiting 2025-01-12
Trial Details
NCT Number NCT05845424
Lead Sponsor Samsung Medical Center
Conditions Coronary Artery Calcification, Metabolic Syndrome, Dyslipidemias
Enrollment 6,000 participants
Start Date 2023-07-03
Primary Completion 2029-06-30 (estimated)
Study Completion 2030-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-01-14